Parmax Pharma Ltd
Parmax Pharma Ltd Share Price Today: Live Updates & Key Insights
Get insights on Parmax Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Parmax Pharma Ltd Share Price Chart
Parmax Pharma Ltd Fundamentals
Traded Volume: null
Market Cap(Cr): null
Avg Traded Price null
1 Year return %
Upper Circuit null
Lower Circuit null
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) null
EPS TTM NaN
Book value NaN
Dividend null%
Parmax Pharma Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Parmax Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Parmax Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W null%
1M null%
3M null%
1Y null%
YTD null%
Parmax Pharma Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Parmax Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday null
Day Before Yesterday null
1W Avg null
1M Avg null
3M Avg null
Parmax Pharma Ltd Technical Details
Parmax Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 null
Support 2 null
Support 3 null
Pivot Point : null
Resistance 1 null
Resistance 2 null
Resistance 3 null
Parmax Pharma Ltd Corporate Actions
Parmax Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Parmax Pharma Ltd’s capital allocation strategies.
Ex-Date
Type
Description
Record Date
Ratio
Parmax Pharma Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Parmax Pharma Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Parmax Pharma Ltd's relative performance and valuation against major competitors.
Stock Name
M. Cap (Cr)
1 Yr Return (%)
P/E (TTM)
PB Ratio
Colinz Laboratories Ltd
₹44.00 (+7.32%)
0.20
-23.50%
23.15
1.17
Parmax Pharma Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Parmax Pharma Ltd, across its operating activities, investing activities, and financing activities.
Parmax Pharma Ltd Shareholding Pattern
This shows the ownership breakdown of Parmax Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter null%
Public null%
Other Institutions null%
FII null%
Mutual Funds null%
About Parmax Pharma Ltd
Incorporated in Nov.`94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax`s pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May`97.
Managing Director
Umang Alkesh Gosalia
Registered office Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala, Rajkot, Gujarat, 360311
FAX :91-2827-270534/535
Background
Incorporation Year 1994
Face Value ₹10.00
Market Lot 1